[Secondary hyperparathyroidism--risk factor for development of cardiovascular complications in patients on

Dejan Petrović1, Biljana Stojimirović

  • 1Klinicki centar Kragujevac, Kragujevac. aca96@eunet.rs

Medicinski Pregled
|March 31, 2011
PubMed

Insights

Secondary hyperparathyroidism significantly contributes to cardiovascular disease in hemodialysis patients. Early detection and management with non-calcium binders, vitamin D, and calcimimetics can reduce cardiovascular complications and mortality.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Context:

  • Cardiovascular disease (CVD) is a primary cause of mortality in patients undergoing hemodialysis.
  • Secondary hyperparathyroidism (SHPT) is a major contributor to CVD in this population.
  • Elevated parathormone, calcium, and phosphate levels, along with a high calcium-x-phosphate product, drive vascular and valvular calcification.

Purpose:

  • To highlight the critical link between SHPT and cardiovascular complications in hemodialysis patients.
  • To emphasize the importance of early screening for vascular/valvular calcification in hemodialysis patients.
  • To advocate for timely intervention strategies to mitigate SHPT-related risks.

Summary:

  • SHPT plays a pivotal role in the pathogenesis of cardiovascular complications, including coronary artery and valvular calcification, among hemodialysis patients.
  • Identifying patients with vascular/valvular calcification is crucial for risk stratification and preventing the progression of coronary artery calcification.
  • Management strategies include utilizing non-calcium-based phosphate binders, novel vitamin D analogs, and calcimimetics.

Impact:

  • These interventions can effectively prevent or slow the development of SHPT and associated cardiovascular complications.
  • Implementing these therapeutic approaches can significantly decrease cardiovascular morbidity and mortality rates in hemodialysis patients.
  • Early detection and management of SHPT are essential for improving long-term outcomes in the hemodialysis population.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...